, Columnist
Did J&J Add to Your Vaccine Confusion?
There are now three Covid-19 shots cleared for use in the U.S. and seven worldwide. Here’s a look at the landscape, what’s ahead and what we still need to know.
When it comes to Covid-19 vaccines, more is better. But which is which?
Photographer: Bing Guan/BloombergThis article is for subscribers only.
Sam Fazeli, a Bloomberg Opinion contributor who covers the pharmaceutical industry for Bloomberg Intelligence, answered questions about Covid-19 vaccine development and the path ahead in the pandemic fight after the U.S. Food and Drug Administration authorized Johnson & Johnson’s shot for emergency use.
J&J's vaccine is the first true one-shot dose to win clearance, and one that’s also easy to store and transport. It’s a good time to take stock of the vaccine landscape. So where are we?